Home › Funds › Edge Wealth Management LLC › ADPT

Edge Wealth Management LLC position in ADPT

ADAPTIVE BIOTECHNOLOGIES COR · Health Care

Edge Wealth Management LLC reported holding 87,000 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.38% of its reported portfolio and ranking #31 among its reported holdings. Edge Wealth Management LLC has disclosed ADPT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)87.00K sh
Reported value held$2.53M
Portfolio Weight0.38%
First reportedQ3 2023
Last changeReduce
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How Edge Wealth Management LLC's ADPT position evolved

Edge Wealth Management LLC first disclosed a stake in ADPT in Q3 2023 at 90,000 shares (US$490K). The position peaked in Q3 2026 at 87,000 shares, worth US$2.5M. Across 13 filings, Edge Wealth Management LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 87,000 shares valued at US$2.5M — a reduction of -3,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 90.00K $490.50K New
Q4 2023 90.00K $441.00K Hold
Q1 2024 90.00K $288.90K Hold
Q2 2024 90.00K $325.80K Hold
Q3 2024 90.00K $460.80K Hold
Q4 2024 90.00K $539.55K Hold
Q1 2025 90.00K $668.70K Hold
Q2 2025 90.00K $1.05M Hold
Q3 2025 90.00K $1.35M Hold
Q4 2025 90.00K $1.46M Hold
Q1 2026 90.00K $1.25M Hold
Q2 2026 90.00K $1.93M Hold
Q3 2026 87.00K $2.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADPT and 13F data

ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 53 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADPT

All ADPT fund holders →

FAQ

How long has Edge Wealth Management LLC held ADPT?

Edge Wealth Management LLC has disclosed ADPT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Edge Wealth Management LLC's current position in ADPT?

As of Q3 2026, Edge Wealth Management LLC holds 87.00K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $2.53M, representing 0.38% of its reported portfolio and ranking #31.

Has Edge Wealth Management LLC been buying or selling ADPT?

In the latest 13F filing (Q3 2026), Edge Wealth Management LLC reduced its position in ADPT. The position peaked in Q3 2026 at 87.00K shares.

Which other funds hold ADPT?

Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.